Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.912 USD | -0.71% |
|
-8.43% | -16.22% |
02/07 | Lineage Cell Therapeutics Included in Russell 3000 Index | MT |
21/05 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.22% | 17Cr | |
+17.29% | 4.44TCr | |
+41.98% | 4TCr | |
-10.58% | 3.77TCr | |
+30.35% | 3.15TCr | |
-7.79% | 2.73TCr | |
+12.54% | 2.63TCr | |
+42.48% | 1.38TCr | |
+29.69% | 1.25TCr | |
-7.45% | 1.13TCr |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- BioTime, Inc. Appoints Chase C. Leavitt as General Counsel and Corporate Secretary